Zee Media Bureau
New Delhi: Government is all set to roll out Bedaquiline, the first drug for multi-drug resistant TB for trial today.
According to a report in Times of India, Bedaquiline also known as miracle drug is perhaps the first major drug in decades to have a potential to dramatically improve MDR-TB treatment outcome, and reduce the number of people who die from the disease.
It is the first TB drug to be approved by Food and Drug Administration (FDA) in over 40 years and will be made available in six public hospitals across the country, as reported.
India is the world's TB epicentre with over 2.5 million people living with the disease every year.